Hospital News and Research

RSS

The connection between severe COVID-19 and white blood cell counts

However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.

19 Oct 2020

Study points out key variations in hospice transitions and experiences

Terminally ill patients referred to hospice care from a hospital setting tend to be on hospice for shorter periods than those who enter hospice while living at home or in a residential care facility.

19 Oct 2020

Cell nucleus may play role in enabling cells to evade crowded environments

Like people, cells in the human body protect their personal space. They seem to know how much space they need, and if it gets too tight, most cells prefer to break free.

19 Oct 2020

New project to use plasma jets to decontaminate vital medical equipment exposed to Covid-19 virus

A NEW project developed by Lancaster University's Health Innovation Campus and Material Science Institute will see pioneering technology used to decontaminate vital medical equipment exposed to the Covid-19 virus, via a partnership with University Hospitals of Morecambe Bay NHS Foundation Trust.

19 Oct 2020

Temple researchers identify criteria to predict cytokine storm in COVID-19 patients

Like a cold front that moves in, setting the stage for severe weather, coronavirus infection triggers showers of infection-fighting immune molecules - showers that sometimes escalate into a chaotic immune response known as a cytokine storm.

19 Oct 2020

Study finds characteristics of nursing home residents more likely to be hospitalized after ED visit

Transfers from the nursing home to the emergency department (ED) or the hospital can have negative longer-term impact on the health of older adults.

19 Oct 2020

Immunoglobulin M ACE2 autoantibodies associated with severe COVID-19

As the COVID-19 pandemic progresses with little prospect of immediate relief, a recent study by Johns Hopkins University researchers published on the preprint server medRxiv* in October 2020 discusses the association of Immunoglobulin M (IgM) autoantibodies against the host receptor that binds severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with severe disease via vascular endothelial damage. This could help develop better therapies and prognostic criteria.

19 Oct 2020

Three new research teams aim to improve therapies for difficult-to-treat pediatric cancers

While incredible progress has been made in advancing pediatric cancer research, critical unmet needs still exist, especially for more aggressive cancers such as neuroblastomas and Ewing sarcoma.

19 Oct 2020

UVA Health still squeezing money from patients — by seizing their home equity

Doris Hutchinson wanted to use money from the sale of her late mother's house to help her grandchildren go to college.

19 Oct 2020

Health care groups dive into property tax ballot fight, eyeing public health money

A November ballot initiative to raise property taxes on big-business owners in California is drawing unconventional political support from health care power players and public health leaders.

19 Oct 2020

Children diagnosed with ADHD, autism frequently visit hospitals and doctors during infancy

Children who are later diagnosed with autism and/or attention deficit hyperactivity disorder visit doctors and hospitals more often in their first year of life than non-affected children, suggesting a potential new way to identify the conditions early.

19 Oct 2020

Elevated birth weight is linked with atrial fibrillation later in life, shows study

Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC).

19 Oct 2020

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.

18 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

Telemedicine use in the ER can yield positive results for patients and providers

Telemedicine has become more common given the current global pandemic. COVID-19 has limited doctor's office and hospital visits to ensure safety for everyone.

16 Oct 2020

NAM announces winners of the inaugural round of Healthy Longevity Catalyst Awards

The National Academy of Medicine, together with seven global collaborators representing nearly 50 countries and territories, today announced the winners of the inaugural round of Healthy Longevity Catalyst Awards.

16 Oct 2020

Experimental ALS drug shows potential to prolong patient survival

An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, has now demonstrated the potential to also prolong patient survival.

16 Oct 2020

Pooled testing for Covid-19 could significantly increase testing capacity

In a series of recommendations to fix the struggling Covid-19 test, trace and isolate system in England, health researchers from University College London and the London School of Hygiene & Tropical Medicine say that pooled testing for Covid-19 could significantly increase testing capacity in a relatively short space of time and help with the identification of asymptomatic cases in key workers.

16 Oct 2020

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

16 Oct 2020

New video campaign highlights how anesthetists are ‘always ready’ on the medical frontline

More than 50 anesthetists across Australia have participated in a new video campaign that highlights how they are ‘always ready’ on the medical frontline.

16 Oct 2020

Hospital News and Research

The connection between severe COVID-19 and white blood cell counts

Study points out key variations in hospice transitions and experiences

Cell nucleus may play role in enabling cells to evade crowded environments

New project to use plasma jets to decontaminate vital medical equipment exposed to Covid-19 virus

Temple researchers identify criteria to predict cytokine storm in COVID-19 patients

Study finds characteristics of nursing home residents more likely to be hospitalized after ED visit

Immunoglobulin M ACE2 autoantibodies associated with severe COVID-19

Three new research teams aim to improve therapies for difficult-to-treat pediatric cancers

UVA Health still squeezing money from patients — by seizing their home equity

Health care groups dive into property tax ballot fight, eyeing public health money

Children diagnosed with ADHD, autism frequently visit hospitals and doctors during infancy

Elevated birth weight is linked with atrial fibrillation later in life, shows study

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

New tool can provide non-invasive decision support for NSCLC treatment

Telemedicine use in the ER can yield positive results for patients and providers

NAM announces winners of the inaugural round of Healthy Longevity Catalyst Awards

Experimental ALS drug shows potential to prolong patient survival

Pooled testing for Covid-19 could significantly increase testing capacity

NIH launches adaptive Phase 3 clinical trial to test immune modulator drugs in COVID-19 patients

New video campaign highlights how anesthetists are ‘always ready’ on the medical frontline

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News